ETF Managers Group’s AbbVie ABBV Stock Holding History

ETF Managers Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$142K	Buy	+894	New	+$137K	﹤0.01%	614
2022 Q4	–	Sell	-1,275	Closed	-$171K	–	514
2022 Q3	$171K	Buy	1,275 +43	+3%	+$6.17K	0.01%	613
2022 Q2	$190K	Sell	1,232 -333	-21%	-$50.9K	0.01%	648
2022 Q1	$256K	Sell	1,565 -1,682	-52%	-$244K	0.01%	582
2021 Q4	$441K	Sell	3,247 -1,240	-28%	-$146K	0.01%	535
2021 Q3	$488K	Buy	4,487 +1,276	+40%	+$146K	0.01%	540
2021 Q2	$361K	Sell	3,211 -4,299	-57%	-$484K	0.01%	577
2021 Q1	$802K	Sell	7,510 -4,686	-38%	-$501K	0.01%	308
2020 Q4	$1.28M	Buy	12,196 +5,139	+73%	+$494K	0.03%	224
2020 Q3	$613K	Buy	7,057 +735	+12%	+$69.2K	0.02%	271
2020 Q2	$610K	Sell	6,322 -894	-12%	-$78.7K	0.02%	243
2020 Q1	$543K	Buy	+7,216	New	+$615K	0.03%	197
2019 Q2	–	Sell	-2,657	Closed	-$214K	–	565
2019 Q1	$214K	Sell	2,657 -994	-27%	-$81.3K	0.01%	293
2018 Q4	$337K	Sell	3,651 -3,234	-47%	-$284K	0.02%	259
2018 Q3	$651K	Sell	6,885 -20,442	-75%	-$1.94M	0.02%	205
2018 Q2	$7.56M	Buy	27,327 +11,405	+72%	+$1.11M	0.55%	42
2018 Q1	$1.46M	Buy	+15,922	New	+$1.75M	0.09%	142

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ETF Managers Group's ABBV Position: Q1 2023 in Review

ETF Managers Group opened a new position in AbbVie (ABBV) in Q1 2023: 894 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #614 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in ABBV as recently as Q3 2022.

ETF Managers Group first reported a position in ABBV in Q1 2018 and has held it in 17 quarters since. The position peaked at $7.56M in Q2 2018. 3,141 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

ETF Managers Group held 894 shares of AbbVie worth $142K as of Q1 2023.
AbbVie was a new ETF Managers Group position in Q1 2023.
AbbVie made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #614 holding.
ETF Managers Group first reported a position in AbbVie in Q1 2018 and has held it in 17 quarters since.
ETF Managers Group's AbbVie position peaked at $7.56M in Q2 2018.
3,141 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.